This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
| less than a minute read

Anticompetitive agreements in the pharmaceutical sector in United Kingdom

Our latest contribution to Lexology Panoramic: Pharmaceutical Antitrust 2026 provides an overview of the UK competition law framework as it applies to the pharmaceutical sector, exploring the evolving enforcement landscape and the issues most relevant to companies operating in this highly regulated market.

An extract of the article can be found here, and the full article is accessible as part of the full Lexology Panoramic guide here (subscription required).

Subscribe to receive our latest insights - on the topics that matter most to you - direct to your inbox, at your preferred frequency. Subscribe here

Tags

antitrust, pharmaceutical sector, competition law, competition litigation, life sciences regulatory, life sciences, article